Maternal gamma-cystathionase deficiency: absence of both teratogenic effects and pregnancy complications

Am J Obstet Gynecol. 1999 Sep;181(3):753-5. doi: 10.1016/s0002-9378(99)70525-9.

Abstract

gamma-Cystathionase deficiency (cystathioninemia-cystathioninuria) is a disorder of the transsulfuration pathway characterized by the accumulation of cystathionine in blood and urine. There are probably no clinical consequences. However, maternal gamma-cystathionase deficiency has not been reported. We studied 2 pregnancies and the offspring of these pregnancies in a woman with the pyridoxine-nonresponsive form of the disorder. The outcomes were favorable, suggesting that maternal gamma-cystathionase deficiency may not be deleterious to the pregnant woman or the fetus.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Cystathionine / blood
  • Cystathionine / urine
  • Cystathionine gamma-Lyase / deficiency*
  • Female
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Complications*
  • Pregnancy Outcome*

Substances

  • Cystathionine
  • Cystathionine gamma-Lyase